UPDATED Apr 15, 2024
Companies with a Value score of at least 3, ordered by Value score
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
H1UM34 | US$36.16 | 2.3% | -36.2% | US$37.9b | US$44.84 | PE15.2x | E11.0% | 1.1% | ||
KRSA3 | R$0.68 | -13.9% | -33.3% | R$522.6m | R$1.55 | PB0.5x | E100.4% | n/a | ||
DASA3 | R$4.49 | -20.7% | -44.0% | R$3.4b | R$11.00 | PB0.5x | E141.1% | 0% | ||
C1NC34 | US$378.72 | 3.8% | 10.2% | US$38.9b | US$462.07 | PE14.4x | E9.0% | n/a | ||
CVSH34 | US$35.84 | -2.8% | -4.9% | US$86.9b | US$45.97 | PE10.4x | E7.1% | 3.9% | ||
QUAL3 | R$1.37 | -18.9% | -64.9% | R$382.6m | R$3.88 | PB0.3x | E83.4% | 5.8% | ||
T2DH34 | US$2.34 | -6.4% | -48.6% | US$2.3b | US$3.44 | PB1x | E47.7% | n/a | ||
VVEO3 | R$6.50 | -7.3% | -59.9% | R$2.1b | R$16.73 | PE5.8x | E21.7% | 4.3% | ||
Q1UE34 | US$328.82 | 0% | n/a | US$14.3b | US$364.02 | PE16.8x | E8.2% | 2.3% | ||
BALM3 | R$12.00 | 0% | n/a | R$110.0m | n/a | PE11.5x | n/a | 2.1% | ||
U1HS34 | US$188.97 | 0% | n/a | US$11.7b | US$204.85 | PE16.3x | E12.1% | 0.5% | ||
PHGN34 | €100.53 | 0% | 14.2% | €17.3b | €107.07 | PB1.4x | E66.3% | n/a | ||
MATD3 | R$5.40 | -6.6% | -33.4% | R$2.1b | R$9.98 | PE17.2x | E29.5% | 1.3% | ||
A2HC34 | US$16.93 | 0% | n/a | US$974.7m | US$24.05 | PB0.6x | E107.1% | n/a | ||
ONCO3 | R$7.67 | -9.1% | -11.5% | R$3.9b | R$16.67 | PE17.4x | E32.5% | n/a | ||
FLRY3 | R$14.32 | -4.0% | 4.2% | R$7.8b | R$19.90 | PE18.4x | E24.1% | 4.1% | ||
C1IC34 | US$452.65 | 0% | 41.9% | US$99.2b | US$494.87 | PE19.2x | E9.6% | 1.6% | ||
H1CA34 | US$83.39 | 1.2% | 23.6% | US$85.3b | US$88.19 | PE16.3x | E6.4% | 0.8% | ||
UNHH34 | US$33.14 | 1.2% | -7.3% | US$410.8b | US$42.52 | PE18.4x | E9.4% | 1.7% | ||
DVAI34 | US$680.05 | 1.0% | 64.7% | US$11.4b | US$683.34 | PE16.5x | E6.4% | n/a | ||
RDOR3 | R$23.97 | -5.7% | 5.3% | R$54.0b | R$34.27 | PE26.5x | E24.3% | 1.5% | ||
CLOV34 | US$3.40 | -6.8% | -20.9% | US$315.1m | US$7.13 | PB1.1x | E32.0% | n/a | ||
XRAY34 | US$167.00 | 0% | n/a | US$6.4b | US$197.17 | PS1.6x | E40.1% | 2.1% | ||
O2PC34 | US$39.67 | 0% | n/a | US$5.5b | US$48.10 | PE21.8x | E-6.2% | n/a |